monitoring the aggressive drug regimens your patients are taking for rheumatoid arthritis

July 2012

You'll see more emphasis on monitoring the aggressive drug regimens your patients are taking for rheumatoid arthritis.

These patients often end up on multiple meds to prevent joint damage...reduce disability...and improve long-term outcomes.

But these aggressive combinations of disease-modifying antirheumatic drugs (DMARDs) need to be closely watched.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote